PROCEPT BioRobotics Corporation (PRCT)

NASDAQ: PRCT · IEX Real-Time Price · USD
46.78
+0.88 (1.92%)
Dec 2, 2022 4:00 PM EST - Market closed
1.92%
Market Cap 2.05B
Revenue (ttm) 61.37M
Net Income (ttm) -77.33M
Shares Out 44.64M
EPS (ttm) 0.67
PE Ratio 69.82
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 299,713
Open 44.98
Previous Close 45.9
Day's Range 43.59 - 47.75
52-Week Range 15.38 - 52.4
Beta n/a
Analysts Buy
Price Target 53.68 (+14.7%)
Earnings Date Nov 3, 2022

About PRCT

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United St... [Read more]

Industry Medical Devices
IPO Date Sep 15, 2021
Employees 234
Stock Exchange NASDAQ
Ticker Symbol PRCT
Full Company Profile

Financial Performance

In 2021, PRCT's revenue was $34.47 million, an increase of 346.72% compared to the previous year's $7.72 million. Losses were -$59.85 million, 12.9% more than in 2020.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for PRCT stock is "Buy." The 12-month stock price forecast is 53.68, which is an increase of 14.75% from the latest price.

Price Target
$53.68
(14.75% upside)
Analyst Consensus: Buy
Stock Forecasts

News

PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Tops Revenue Estimates

PROCEPT BioRobotics Corporation (PRCT) delivered earnings and revenue surprises of -8.51% and 17.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

1 month ago - Zacks Investment Research

PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing trans...

1 month ago - GlobeNewsWire

PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

PROCEPT BioRobotics Corporation (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

PROCEPT BioRobotics Announces $52 Million Debt Refinancing

REDWOOD CITY, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing trans...

1 month ago - GlobeNewsWire

Leading Medical Stocks, Including Sensus And Shockwave, Have Grown At Least 36% This Year

Biotech isn't the only place investors in health care stocks can make money in 2022. Take a look at leading medical-equipment stocks.

Other symbols: AXNXHAESRTSSWAV
1 month ago - Investors Business Daily

3 Resilient Medical Stocks to Watch as Rate Hikes Continue

Here we discuss three Medical-Instruments stocks - TMDX, PRCT & SRTS - that continued to grow in the first nine months of 2022 even though three Fed rate hikes dragged broader indices down.

Other symbols: SRTSTMDX
2 months ago - Zacks Investment Research

PROCEPT BioRobotics Corp. to Present at 2022 Wells Fargo Healthcare Conference

REDWOOD CITY, Calif., Aug. 22, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

3 months ago - GlobeNewsWire

PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

REDWOOD CITY, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing trans...

4 months ago - GlobeNewsWire

PROCEPT BioRobotics to Report Second Quarter 2022 Financial Results on August 4, 2022

REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

4 months ago - GlobeNewsWire

PROCEPT BioRobotics Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

REDWOOD CITY, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transf...

6 months ago - GlobeNewsWire

PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of A...

REDWOOD CITY, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solut...

7 months ago - GlobeNewsWire

Andreas Halvorsen Powers Down Position in PROCEPT BioRobotics

Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed earlier this week he curbed his PROCEPT BioRobotics Corp. ( PRCT , Financial) stake by 25.45%.

8 months ago - GuruFocus

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results

REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative s...

8 months ago - GlobeNewsWire

Procept BioRobotics' Aquablation Therapy Shows Encouraging Five-Year Data In Prostate Gland Enlargement

Procept BioRobotics Corp (NASDAQ: PRCT) announced five-year results from the WATER study comparing Aquablation therapy to TURP, the historical standard of care for treating benign prostatic hyperplasia ...

9 months ago - Benzinga

PROCEPT Announces 5-Year WATER Study Data Comparing Aquablation to TURP

– Symptom reduction and uroflow improvement proved durable and consistent compared to TURP

9 months ago - GlobeNewsWire

6 Underperforming IPO Stocks To Buy On The Dip

The U.S. IPO market was red-hot in 2021. The total number of traditional U.S. IPOs hit its highest level since the dot-com boom in the late 1990s, while total IPO deal value reached record levels last y...

Other symbols: FDMTFWRGNRDSOMICVECT
10 months ago - Benzinga

PROCEPT BioRobotics Corp. to Present at 11th Annual SVB Leerink Global Healthcare Conference and Cowen's 42nd Annual ...

REDWOOD CITY, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

10 months ago - GlobeNewsWire

Northside Healthcare System in Atlanta Advances Surgical Robotics Program with Multi-System, Multi-Hospital Agreement...

First and only image-guided, heat-free surgical robotic procedure aims to establish a new standard of care for patients with enlarged prostates First and only image-guided, heat-free surgical robotic pr...

10 months ago - GlobeNewsWire

PROCEPT BioRobotics Corp. Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

REDWOOD CITY, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

10 months ago - GlobeNewsWire

PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors

REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

11 months ago - GlobeNewsWire

PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance

REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) --  PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solut...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Appoints Elisabeth Sandoval to Board of Directors

REDWOOD CITY, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021

REDWOOD CITY, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative soluti...

1 year ago - GlobeNewsWire

PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy

REDWOOD CITY, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solut...

1 year ago - GlobeNewsWire

Andreas Halvorsen Assembles Position in PROCEPT BioRobotics

Viking Global leader Andreas Halvorsen (Trades, Portfolio) disclosed a position in PROCEPT BioRobotics Corp. ( PRCT , Financial) earlier this week, seeing a value opportunity in a newly public company.

1 year ago - GuruFocus